Tobira files for IPO; withdrawn, then revived two months later; once again withdrawn

10 Jun 2021

Tobira Therapeutics Inc. (developing cenicriviroc for multiple diseases) filed for its initial public offering.

Already a Biomedtracker subscriber? You have access to the full deal record through your subscription

Want to become a subscriber? Subscribers get more deal details, updates, deal financials and deal products.

Questions?

Please contact Sales at: (212) 520-2765 or email [email protected]

Related Companies

Tobira files for IPO; withdrawn, then revived two months later; once again withdrawn

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

DCD.EmailPopout.Notice